Exchange transfusion in the neonate: a controlled study using frozen-stored erythrocytes resuspended in plasma.
During a nine-month period 43 consecutive infants who needed exchange transfusions for the management of their hyperbilirubinemia randomly received whole blood less than 5 days old (control group) or frozen erythrocytes diluted in plasma (experimental groups). There was no different prior to and after exchange transfusions in total protein, albumin, globulin, immunoglobulins, bilirubin, and hematocrit in the control group versus the experimental group. The efficacies of bilirubin removal, as measured by delta bilirubin, were the same in the two groups. Advantages of exchange transfusion with freeze-preserved erythrocytes suspended in type-specific plasma are discussed.
D001663:Bilirubin / Q000097:blood; D001793:Blood Preservation / Q000379:methods*; D001798:Blood Proteins / Q000032:analysis; D004899:Erythroblastosis, Fetal / Q000097:blood / Q000628:therapy; D004912:Erythrocytes; D005078:Exchange Transfusion, Whole Blood / Q000379:methods*; D005260:Female; D005615:Freezing; D006801:Humans; D006932:Hyperbilirubinemia / Q000097:blood / Q000628:therapy; D007136:Immunoglobulins / Q000032:analysis; D007231:Infant, Newborn; D011247:Pregnancy; D011446:Prospective Studies
D001798:Blood Proteins; D007136:Immunoglobulins; D001663:Bilirubin